These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35493470)

  • 1. A Short Peptide of Autotransporter Ata Is a Promising Protective Antigen for Vaccination Against
    Sun P; Li X; Pan C; Liu Z; Wu J; Wang H; Zhu L
    Front Immunol; 2022; 13():884555. PubMed ID: 35493470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections.
    Bentancor LV; Routray A; Bozkurt-Guzel C; Camacho-Peiro A; Pier GB; Maira-Litrán T
    Infect Immun; 2012 Oct; 80(10):3381-8. PubMed ID: 22825448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The
    Weidensdorfer M; Ishikawa M; Hori K; Linke D; Djahanschiri B; Iruegas R; Ebersberger I; Riedel-Christ S; Enders G; Leukert L; Kraiczy P; Rothweiler F; Cinatl J; Berger J; Hipp K; Kempf VAJ; Göttig S
    Virulence; 2019 Dec; 10(1):68-81. PubMed ID: 31874074
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii.
    Bentancor LV; Camacho-Peiro A; Bozkurt-Guzel C; Pier GB; Maira-Litrán T
    J Bacteriol; 2012 Aug; 194(15):3950-60. PubMed ID: 22609912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A conserved region of Acinetobacter trimeric autotransporter adhesion, Ata, provokes suppression of Acinetobacter baumannii virulence.
    Hatefi Oskuei R; Darvish Alipour Astaneh S; Rasooli I
    Arch Microbiol; 2021 Aug; 203(6):3483-3493. PubMed ID: 33907866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of a new glycoengineered vaccine against Acinetobacter baumannii in mice.
    Li X; Pan C; Liu Z; Sun P; Hua X; Feng E; Yu Y; Wu J; Zhu L; Wang H
    Microb Biotechnol; 2022 Feb; 15(2):703-716. PubMed ID: 33755314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The
    Tram G; Poole J; Adams FG; Jennings MP; Eijkelkamp BA; Atack JM
    ACS Infect Dis; 2021 Aug; 7(8):2352-2361. PubMed ID: 34339169
    [No Abstract]   [Full Text] [Related]  

  • 8. InvL, an Invasin-Like Adhesin, Is a Type II Secretion System Substrate Required for Acinetobacter baumannii Uropathogenesis.
    Jackson-Litteken CD; Di Venanzio G; Le NH; Scott NE; Djahanschiri B; Distel JS; Pardue EJ; Ebersberger I; Feldman MF
    mBio; 2022 Jun; 13(3):e0025822. PubMed ID: 35638734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and evaluation of a multi-epitope assembly peptide vaccine against Acinetobacter baumannii infection in mice.
    Ren S; Guan L; Dong Y; Wang C; Feng L; Xie Y
    Swiss Med Wkly; 2019 Jun; 149():w20052. PubMed ID: 31203576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of trimeric autotransporter adhesins and their potential as vaccine targets.
    Thibau A; Dichter AA; Vaca DJ; Linke D; Goldman A; Kempf VAJ
    Med Microbiol Immunol; 2020 Jun; 209(3):243-263. PubMed ID: 31788746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.
    Huang W; Wang S; Yao Y; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Ma Y
    Vaccine; 2015 Aug; 33(36):4479-85. PubMed ID: 26207591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against
    Du X; Xue J; Jiang M; Lin S; Huang Y; Deng K; Shu L; Xu H; Li Z; Yao J; Chen S; Shen Z; Feng G
    Int J Nanomedicine; 2021; 16():1819-1836. PubMed ID: 33707942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.
    Huang W; Yao Y; Wang S; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Chu X; Bai H; Yao Y; Ma Y
    Sci Rep; 2016 Feb; 6():20724. PubMed ID: 26853590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccine encoding OmpA and Pal from Acinetobacter baumannii efficiently protects mice against pulmonary infection.
    Lei L; Yang F; Zou J; Jing H; Zhang J; Xu W; Zou Q; Zhang J; Wang X
    Mol Biol Rep; 2019 Oct; 46(5):5397-5408. PubMed ID: 31342294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii.
    McConnell MJ; Domínguez-Herrera J; Smani Y; López-Rojas R; Docobo-Pérez F; Pachón J
    Infect Immun; 2011 Jan; 79(1):518-26. PubMed ID: 20974823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Omp34 antibodies protect against Acinetobacter baumannii in a murine sepsis model.
    Naghipour Erami A; Rasooli I; Jahangiri A; Darvish Alipour Astaneh S
    Microb Pathog; 2021 Dec; 161(Pt B):105291. PubMed ID: 34798280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Different Methods for Preparing
    Li S; Chen DQ; Ji L; Sun S; Jin Z; Jin ZL; Sun HW; Zeng H; Zhang WJ; Lu DS; Luo P; Zhao AN; Luo J; Zou QM; Li HB
    Front Immunol; 2020; 11():1069. PubMed ID: 32655550
    [No Abstract]   [Full Text] [Related]  

  • 18. Trimeric autotransporter adhesins in Acinetobacter baumannii, coincidental evolution at work.
    Rahbar MR; Zarei M; Jahangiri A; Khalili S; Nezafat N; Negahdaripour M; Fattahian Y; Ghasemi Y
    Infect Genet Evol; 2019 Jul; 71():116-127. PubMed ID: 30922803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection.
    Ainsworth S; Ketter PM; Yu JJ; Grimm RC; May HC; Cap AP; Chambers JP; Guentzel MN; Arulanandam BP
    Vaccine; 2017 Jun; 35(26):3387-3394. PubMed ID: 28522011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel approach of virulome based reverse vaccinology for exploring and validating peptide-based vaccine candidates against the most troublesome nosocomial pathogen: Acinetobacter baumannii.
    Ahmad S; Azam SS
    J Mol Graph Model; 2018 Aug; 83():1-11. PubMed ID: 29753164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.